540P - Prospective evaluation of BRAF, PI3K and PTEN as predictive and prognostic biomarkers in first-line advanced KRAS wild-type colorectal cancer treated with FOLFOX or FOLFIRI plus bi-weekly cetuximab. GEMCAD 10-02
| Autor: | Alonso, V., Emperador, P. Escudero, Urena, M. Mendez, Gallego, J., Rodriguez, J.R., Fernández, J., Salud, A., Falcó, E., Manzano, H., Zanui, M., Gil, M., Sarmiento, U. Bohn, Martos, C. Fernández, Calderero, V., Ferrer, A.I., Cuatrecasas, M., Rojo, F., Feliu, J., Maurel, J., García-Albéniz, X. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi178-vi178 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|